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(ADP-ribose) glycohydrolase (PARG) enzymes and the 
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described. PARG is involved in the cellular response to 
DNA damage and its proper function is associated With the 
body’s response to neoplastic disorder inducing agents and 
oxidative stress. Expression vectors containing the cDNAs 
and cells transformed With the vectors are described. Probes 
and primers that hybridize With the cDNAs are described. 
Expression of the cDNA in E. coli results in an enzymati 
cally active protein of about 111 kDa and an active fragment 
of about 59 kDa. Methods for inhibiting PARG expression 
or overexpressing PARG in a subject for therapeutic bene?t 
are described. Exemplary of PARG inhibitors are anti-sense 
oligonucleotides. The invention has implications for treat 
ment of neoplastic disorder, heart attack, stroke, and neu 
rodegenerative diseases. Methods for detecting a mutant 
PARG allele are also described. Antibodies immunoreactive 
With PARGs and fragments thereof are described. 
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FIGURE 13 
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FIGURE 14 
Strategy to Obtain Homologous 
PARG Sequences 
bovine PARG Sequence 
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FIGURE 16 
Multiple Alignment of Amino Acid Sequences of PARG 
from Different Species 
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FIGURE 17 
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FIGURE 18 
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FIGURE 19 
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